首页> 外国专利> ANTIBODY AGAINST GLIPICAN-3 WITH IMPROVED KINETIC INDICATORS IN PLASMA

ANTIBODY AGAINST GLIPICAN-3 WITH IMPROVED KINETIC INDICATORS IN PLASMA

机译:抗GLIPICAN-3抗体并改善了血浆中的运动学指标

摘要

1. The antibody against glypican-3, which contains the variable region of the heavy chain of SEQ ID NO: 27 and the variable region of the light chain of SEQ ID NO: 29. ! 2. The antibody according to claim 1, containing a constant region of a human antibody. ! 3. The antibody according to claim 2, where the constant region contains the sequence of SEQ ID NO: 32 and 33.! 4. The antibody according to claim 1, where the antibody has a reduced amount of fucose attached to the Fc region of the antibody. ! 5. An anticancer composition comprising an effective amount of an antibody according to any one of claims 1 to 4 and a pharmaceutically acceptable carrier. ! 6. An anti-cancer agent containing an antibody according to claims 1 to 4 as an active ingredient. ! 7. The anti-cancer agent of claim 6, wherein the cancer is liver cancer. ! 8. A nucleic acid that encodes an antibody polypeptide according to any one of claims 1 to 4. ! 9. A host cell containing the nucleic acid of claim 8, for the production of antibodies according to any one of claims 1 to 4. ! 10. The host cell according to claim 9, where the host cell is an animal cell lacking a fucose transporter, an animal cell with fucosyl transferase removed, or an animal cell with a modified branched sugar chain. ! 11. A method for producing an antibody, comprising culturing a host cell according to claim 9 or 10 and isolating the polypeptide from the cell culture.
机译:1.针对glypican-3的抗体,其包含SEQ ID NO:27的重链的可变区和SEQ ID NO:29的轻链的可变区。 2.根据权利要求1的抗体,其包含人抗体的恒定区。 ! 3.根据权利要求2的抗体,其中恒定区包含SEQ ID NO:32和33的序列。 4.根据权利要求1所述的抗体,其中所述抗体具有减少量的连接至所述抗体的Fc区的岩藻糖。 ! 5.一种抗癌组合物,其包含有效量的根据权利要求1-4中任一项的抗体和药学上可接受的载体。 ! 6.一种抗癌剂,其包含根据权利要求1-4的抗体作为活性成分。 ! 7.权利要求6的抗癌剂,其中所述癌症是肝癌。 ! 8.一种核酸,其编码根据权利要求1-4中任一项的抗体多肽。 9.包含权利要求8的核酸的宿主细胞,用于产生权利要求1-4中任一项的抗体。 10.根据权利要求9的宿主细胞,其中所述宿主细胞是缺少岩藻糖转运蛋白的动物细胞,去除了岩藻糖基转移酶的动物细胞或具有修饰的分支糖链的动物细胞。 ! 11.一种产生抗体的方法,包括培养根据权利要求9或10的宿主细胞,并从细胞培养物中分离多肽。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号